Insulin Fills by Medicare Enrollees and Out-of-Pocket Caps Under the Inflation Reduction Act.
作者信息
Myerson Rebecca, Qato Dima M, Goldman Dana P, Romley John A
机构信息
Department of Population Health Sciences, University of Wisconsin, Madison.
School of Pharmacy, University of Southern California, Los Angeles.
出版信息
JAMA. 2023 Aug 15;330(7):660-662. doi: 10.1001/jama.2023.12951.
Abstract
摘要
相似文献
1
Insulin Fills by Medicare Enrollees and Out-of-Pocket Caps Under the Inflation Reduction Act.医疗保险参保者的胰岛素费用报销情况以及《降低通胀法案》规定的自付费用上限。
JAMA. 2023 Aug 15;330(7):660-662. doi: 10.1001/jama.2023.12951.
2
Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.年度美元限额或“上限”对医疗保险患者处方药福利的影响。
JAMA. 2003 Jul 9;290(2):222-7. doi: 10.1001/jama.290.2.222.
3
Average out-of-pocket health care costs for Medicare+Choice enrollees increase substantially in 2002.2002年，医疗保险+选择计划参保人的平均自付医疗保健费用大幅增加。
Issue Brief (Commonw Fund). 2002 Nov(575):1-8.
4
Effect of an expenditure cap on low-income seniors' drug use and spending in a state pharmacy assistance program.支出上限对州药房援助计划中低收入老年人药物使用和支出的影响。
Health Serv Res. 2009 Jun;44(3):1010-28. doi: 10.1111/j.1475-6773.2009.00951.x. Epub 2009 Mar 2.
5
Impact of cost sharing on prescription drugs used by Medicare beneficiaries.医疗保险受益人的处方药费用分担的影响。
Res Social Adm Pharm. 2010 Jun;6(2):100-9. doi: 10.1016/j.sapharm.2010.03.003. Epub 2010 May 7.
6
Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Risk Factors Under the Inflation Reduction Act.《平价医疗法案下，心血管疾病风险因素的 Medicare 受益人自付药品费用》。
J Am Coll Cardiol. 2023 Apr 18;81(15):1491-1501. doi: 10.1016/j.jacc.2023.02.002. Epub 2023 Feb 20.
7
Medicare Prescription Drug Plan Enrollees Report Less Positive Experiences Than Their Medicare Advantage Counterparts.医疗保险处方药计划参保者报告的积极体验少于医疗保险优势计划的参保者。
Health Aff (Millwood). 2016 Mar;35(3):456-63. doi: 10.1377/hlthaff.2015.0816.
8
Prescription drugs: issues of cost, coverage, and quality.处方药：成本、保险范围及质量问题。
EBRI Issue Brief. 1999 Apr(208):1-21.
9
Prescription Drug Spending and Medication Adherence Among Medicare Beneficiaries with Heart Failure.医疗保险受益人心力衰竭患者的处方药支出和药物依从性。
J Manag Care Spec Pharm. 2019 Jun;25(6):705-713. doi: 10.18553/jmcp.2019.25.6.705.
10
Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.医疗保险计划；医疗保险处方药折扣卡。有意见征求期的暂行最终规则。
Fed Regist. 2003 Dec 15;68(240):69839-927.
引用本文的文献
1
Type 2 Diabetes and Financial Outcomes.2型糖尿病与财务状况
JAMA Netw Open. 2025 Jul 1;8(7):e2523453. doi: 10.1001/jamanetworkopen.2025.23453.
2
Prescription Medication Expenditures for Patients With Diabetes in the United States: 2012-2021.美国糖尿病患者的处方药支出：2012 - 2021年
J Diabetes. 2025 Jul;17(7):e70106. doi: 10.1111/1753-0407.70106.
3
"Can I afford to live today?" The emotional toll of navigating the healthcare system with type 1 diabetes.“我今天能负担得起生活费用吗？” 1型糖尿病患者在医疗系统中面临的情感负担。
Front Endocrinol (Lausanne). 2025 Mar 24;16:1555265. doi: 10.3389/fendo.2025.1555265. eCollection 2025.
4
Changes in Out-of-Pocket Drug Expenditures Among Medicare Beneficiaries With Dementia Under the Inflation Reduction Act: A Simulation Study.《降低通胀法案》下患有痴呆症的医疗保险受益人的自付药品费用变化：一项模拟研究
Value Health. 2025 Apr;28(4):553-561. doi: 10.1016/j.jval.2025.01.008. Epub 2025 Jan 27.
5
Commercial prices and their influence on urology practices: Prostate cancer care among men with Medicare.商业价格及其对泌尿外科医疗实践的影响：医疗保险男性人群中的前列腺癌护理
Cancer. 2025 Jan 1;131(1):e35633. doi: 10.1002/cncr.35633. Epub 2024 Nov 5.
6
Health Outcome Changes in Individuals With Type 1 Diabetes After a State-Level Insulin Copayment Cap.州级胰岛素共付额上限对 1 型糖尿病患者健康结局的影响。
JAMA Netw Open. 2024 Aug 1;7(8):e2425280. doi: 10.1001/jamanetworkopen.2024.25280.
7
State Out-Of-Pocket Caps On Insulin Costs: No Significant Increase In Claims Or Utilization.设定胰岛素自付费用上限：索赔或利用率均无显著增加。
Health Aff (Millwood). 2024 Aug;43(8):1137-1146. doi: 10.1377/hlthaff.2024.00118.
8
Patient Out-of-Pocket Costs for Type 2 Diabetes Medications When Aging Into Medicare.当步入老年医保时，2 型糖尿病药物的患者自付费用。
JAMA Netw Open. 2024 Jul 1;7(7):e2420724. doi: 10.1001/jamanetworkopen.2024.20724.
9
Prescription Drug Dispensing and Patient Costs After Implementation of a No Behavioral Health Cost-Sharing Law.实施无行为健康共付额法律后处方药配药和患者费用。
JAMA Health Forum. 2024 Mar 1;5(3):e240198. doi: 10.1001/jamahealthforum.2024.0198.
10
The impact of a statewide insulin copay cap policy for insured patients with diabetes in Utah.犹他州针对参保糖尿病患者的全州胰岛素自付费用上限政策的影响。
J Manag Care Spec Pharm. 2024 Feb 3;30(2):112-117. doi: 10.18553/jmcp.2024.30.2.112.
Zotero 插件